Article
Genetic Influences in Breast Cancer Drug Resistance
1 Feb 2021
Abstract excerpt
Breast cancer is the most common cancer in adult women aged 20 to 50 years. The therapeutic regimens that are commonly recommended to treat breast cancer are human epidermal growth factor receptor 2 (HER2) targeted therapy, endocrine therapy, and systemic chemotherapy. The selection of pharmacotherapy is based on the characteristics of the tumor and its hormone receptor status, specifically, the presence of HER2,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
